+ All Categories
Home > Documents > FARMASAFE@ - Dedalus España...Given this problem, Dedalus GS has designed a technological proposal...

FARMASAFE@ - Dedalus España...Given this problem, Dedalus GS has designed a technological proposal...

Date post: 14-Sep-2020
Category:
Upload: others
View: 24 times
Download: 2 times
Share this document with a friend
2
www.dedalusgs.com Cancer therapy management involves a set of risks, both for the health of the patient receiving the treatment and the health of the professional who manipulates the antineoplastic chemotherapy. As cancer cases are in- creasing and, in proportion, the number of oncological treatments, the question of safety in the area of the therapeutic process of this disease plays an increasingly important role. The "safety" factor has a direct impact on Cancer costs for health systems. Although it is the pathology that cur- rently leads the ranking of health expenditure, the figure continues to increase due to factors such as popula- tion aging, the use of increasingly specialized drugs and the high cost of treatment settings. Given this problem, Dedalus GS has designed a technological proposal that allows the health organization to de- sign a more secure, effective and efficient oncology therapy process thanks to: Procedures design automation, monitoring and standard protocols adoption. Automated preparation of personalized chemotherapy treatments . Processes and actors complete integration. Univocal patient identification guarantee. Active patient in their own therapeutic process. Headquarters España / LATAM: + 34 963 47 91 23 - [email protected]
Transcript
Page 1: FARMASAFE@ - Dedalus España...Given this problem, Dedalus GS has designed a technological proposal that allows the health organization to de sign a more secure, effective and efficient

www.dedalusgs.com

Cancer therapy management involves a set of risks, both for the health of the patient receiving the treatment

and the health of the professional who manipulates the antineoplastic chemotherapy. As cancer cases are in-

creasing and, in proportion, the number of oncological treatments, the question of safety in the area of the

therapeutic process of this disease plays an increasingly important role.

The "safety" factor has a direct impact on Cancer costs for health systems. Although it is the pathology that cur-

rently leads the ranking of health expenditure, the figure continues to increase due to factors such as popula-

tion aging, the use of increasingly specialized drugs and the high cost of treatment settings.

Given this problem, Dedalus GS has designed a technological proposal that allows the health organization to de-

sign a more secure, effective and efficient oncology therapy process thanks to:

Procedures design automation, monitoring and standard protocols adoption.

Automated preparation of personalized chemotherapy treatments .

Processes and actors complete integration.

Univocal patient identification guarantee.

Active patient in their own therapeutic process.

Headquarters España / LATAM: + 34 963 47 91 23 - [email protected]

Page 2: FARMASAFE@ - Dedalus España...Given this problem, Dedalus GS has designed a technological proposal that allows the health organization to de sign a more secure, effective and efficient

ESPAÑA - ARGENTINA - CHILE - COLOMBIA - COSTA RICA- ECUADOR - MÉXICO - PANAMÁ - PERÚ - URUGUAY - USA

• Minimizes human error throughout the process.

• Gives agility and efficiency to the workflow.

• Drugs automated elaboration:

- Increases patient and professional safety.

- Follow biosecurity measures.

- Optimizes cytostatics use and reducing costs.

- Ensures final product sterility.

- Reduces processing time.

- Ensures the completeness and traceability of

the data.

- It allows to centralize the activities

FARMASAFE@ Powerful web solution for computerized management of the comprehensive pharmacotherapy clinical process: from prescription to drug administration, including management of protocols. Farmasafe@ facilitates the work and streamlines the communication of the healthcare team that a-ttends the patient, improving the results of each stage of the drug administration chain.

PHARMODUCT Revolutionary medical device for the automated preparation of personalized chemotherapy treatments capable of producing up to 30 products an hour without the need for direct cytostatic manipulation. Pharmoduct conforms to the biosecurity measures, eliminating the possible adverse events for the professional and guaranteeing the sterility of the final product.

IDENTITY4HEALTH A System based on advanced biometric technology for the unequivocal identification of the pa-tient and the facultative staff through the iris and fingerprint. Identity4Health avoids adverse effects derived from misidentification of the patient, increases the safety of clinical information and provides traceability of medication use and administration.

X-VALUE Platform for the complete integration of the therapeutic process, actors (doctor, pharmacist, nurse and patient) and departments involved in all phases of cancer therapy. X-Value is the tool that allows to process and mark correctly the requirements and the demands of the process, and allows the unified management of the patient's privacy and consent.

mHealthCare Multi-platform mSalud system that allows oncological patients to manage their own therapeutic process from the mobile device or PC, based on specific care plans. With mHealthCare, the practi-tioner incorporates the patient into the platform, designs their care plan, and remotely monitors com-pliance with plan, adherence, and possible decompensation.

• biometric identification:

- Guarantees the unequivocal association "patient-

treatment-moment".

- Accredits the professionals involved in the process

and provides traceability.

• Cancer therapeutic process is integrated in all its

phases with all the actors.

• Population health management policies oriented

solution.

• Facilitates the patient´s “empowerment”.

• Improves clinical and financial results.

• Integrates with hospital information systems and

specialized clinical records.

ONCOLOGIS SOLUTION by Dedalus GS


Recommended